Takeno A
No ORCID on file
· 1 paper in corpus
· active 2024
PurposeThe NY-ESO-1 antigen is highly immunogenic and often spontaneously induces an immune response in patients with cancer. We conducted a large-scale multicenter cohort study to investigate the utility of serum NY-ESO-1 and p53 antibodie…